| Financial Year |
March 31 2023 |
| Monetary Funds |
313,062,444.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
124,786,252.18 |
| Advances to Suppliers |
14,685,561.17 |
| Other Receivables |
2,731,636.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
242,662,374.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,377,735.28 |
| Total Current Assets |
809,359,683.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,200,933.87 |
| Investment Properties |
-- |
| Fixed Assetes |
250,654,540.50 |
| Under-construction Projects |
11,188,511.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,164,496.02 |
| R&D expenses |
-- |
| Goodwill |
112,108,447.82 |
| Long-Term Deferred and Prepaid Expenses |
1,356,841.34 |
| Deferred Income Tax Assets |
3,097,773.76 |
| Other Non-Current Assets |
1,755,250.00 |
| Sub-Total of Non-Current Assets |
461,526,794.40 |
| Total Assets |
1,270,886,477.72 |
| Short-Term Loans |
35,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,850,358.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,957,997.48 |
| Taxes Payable |
10,258,987.82 |
| Interest Payable |
291,472.83 |
| Dividend Payable |
-- |
| Other payables |
33,508,151.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,649,991.94 |
| Sub-Total of Current Liabilities |
252,749,215.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,444,598.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,385,507.14 |
| Total Liabilities |
255,134,722.64 |
| Paid-In Capital(Or Share Stock) |
263,498,500.00 |
| Capital Surplus |
323,639,684.37 |
| Surplus Reserve |
46,251,302.10 |
| LESS:Treasury Stock |
27,736,440.00 |
| Undistributed Profits |
410,098,708.61 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,015,751,755.08 |
| Owner's Equity（Stockholder's Equity） |
1,015,751,755.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,270,886,477.72 |
